The effect of functional MAPKAPK2 copy number variation CNV-30450 on elevating nasopharyngeal carcinoma risk is modulated by EBV infection

Carcinogenesis

Volumn 35, Issue 1, 2014, Pages 46-52

  Yang, Lei ^a   Liu, Bin ^a   Qiu, Fuman ^a   Huang, Binfang ^a   Li, Yinyan ^a   Huang, Dongsheng ^a   Yang, Rongrong ^a   Yang, Xiaorong ^a   Deng, Jieqiong ^b   Jiang, Qingping ^a   Zhou, Yifeng ^b   Lu, Jiachun ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED PROTEIN KINASE 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; COPY NUMBER VARIATION; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RISK ASSESSMENT;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES;

EID: 84891348276     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt314     Document Type: Article

References (49)

1. Jemal,A. et al. (2011) Global cancer statistics. Cancer J. Clin., 61, 69-90.
2. Jia,W.H. et al. (2006) Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer, 6, 178.
3. Gullo,C. et al. (2008) Association of Epstein-Barr virus with nasopharyngeal carcinoma and current status of development of cancer-derived cell lines. Ann. Acad. Med. Singapore, 37, 769-777.
4. Young,L.S. et al. (2004) Epstein-Barr virus: 40 years on. Nat. Rev. Cancer, 4, 757-768.
5. Xu,F.H. et al. (2012) An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein- Barr virus activation. J. Natl Cancer Inst., 104, 1396-1410.
6. Siegel,R. et al. (2012) Cancer statistics, 2012. Cancer J. Clin., 62, 10-29.
7. Hsu,W.L. et al. (2011) Familial tendency and risk of nasopharyngeal carcinoma in taiwan: effects of covariates on risk. Am. J. Epidemiol., 173, 292-299.
8. Ruan,H.L. et al. (2010) Alcohol and tea consumption in relation to the risk of nasopharyngeal carcinoma in Guangdong, China. Front. Med. China, 4, 448-456.
9. Maruyama,J. et al. (2009) Stress-activated MAP kinase cascades in cellular senescence. Curr. Med. Chem., 16, 1229-1235.
10. Chen,C.C. et al. (2010) Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-kappaB and p38 MAPK pathways. Cell. Signal., 22, 1132-1142.
11. Dawson,C.W. et al. (2008) Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J. Virol., 82, 3654-3664.
12. Wu,M. et al. (2009) Signaling transduction network mediated by tumor suppressor/susceptibility genes in NPC. Curr. Genomics, 10, 216-222.
13. Zheng,J. et al. (2012) The protective role of polymorphism MKK4-1304 T>G in nasopharyngeal carcinoma is modulated by Epstein-Barr virus' infection status. Int. J. Cancer, 130, 1981-1990.
14. Ding,L. et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455, 1069-1075.
15. Ronkina,N. et al. (2008) MK2 and MK3-a pair of isoenzymes? Front. Biosci., 13, 5511-5521.
16. ten Hove,W. et al. (2007) Differential regulation of TNFalpha and GM-CSF induced activation of P38 MAPK in neutrophils and eosinophils. Mol. Immunol., 44, 2492-2496.
17. Manke,I.A. et al. (2005) MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol. Cell, 17, 37-48.
18. Jackson,R.M. et al. (2008) Kinase activity, heat shock protein 27 phosphorylation, and lung epithelial cell glutathione. Exp. Lung Res., 34, 245-262.
19. Wu,R. et al. (2007) Hsp27 regulates Akt activation and polymorphonuclear leukocyte apoptosis by scaffolding MK2 to Akt signal complex. J. Biol. Chem., 282, 21598-21608.
20. Ronkina,N. et al. (2010) MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin. Biochem. Pharmacol., 80, 1915-1920.
21. Maitra,S. et al. (2008) The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2. RNA, 14, 950-959.
22. Birner,P. et al. (2012) MAPKAP kinase 2 overexpression influences prognosis in gastrointestinal stromal tumors and associates with copy number variations on chromosome 1 and expression of p38 MAP kinase and ETV1. Clin. Cancer Res., 18, 1879-1887.
23. Pomérance,M. et al. (2006) High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms. J. Pathol., 209, 298-306.
24. Stearman,R.S. et al. (2005) Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am. J. Pathol., 167, 1763-1775.
25. Gabeau-Lacet,D. et al. (2009) Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome. J. Neuropathol. Exp. Neurol., 68, 1155-1165.
26. Jansen,M. et al. (2012) Gain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survival. Neuropathol. Appl. Neurobiol., 38, 213-219.
27. Liu,B. et al. (2012) A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer. Am. J. Hum. Genet., 91, 384-390.
28. Hu,Z. et al. (2011) A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat. Genet., 43, 792-796.
29. Bei,J.X. et al. (2010) A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat. Genet., 42, 599-603.
30. Fachiroh,J. et al. (2012) Tobacco consumption and genetic susceptibility to nasopharyngeal carcinoma (NPC) in Thailand. Cancer Causes Control, 23, 1995-2002.
31. Zheng,J. et al. (2013) A sequence polymorphism in miR-608 predicts recurrence after radiotherapy for nasopharyngeal carcinoma. Cancer Res., 73, 5151-5162.
32. Zheng,J. et al. (2011) Functional NBS1 polymorphism is associated with occurrence and advanced disease status of nasopharyngeal carcinoma. Mol. Carcinog., 50, 689-696.
33. Lu,J. et al. (2011) The polymorphism and haplotypes of PIN1 gene are associated with the risk of lung cancer in Southern and Eastern Chinese populations. Hum. Mutat., 32, 1299-1308.
34. Yang,L. et al. (2012) A functional polymorphism at microRNA-629-binding site in the 3'-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. Carcinogenesis, 33, 338-347.
35. Tse,K.P. et al. (2011) A gender-specific association of CNV at 6p21.3 with NPC susceptibility. Hum. Mol. Genet., 20, 2889-2896.
36. Mayo,P. et al. (2010) CNV analysis using TaqMan copy number assays. Curr. Protoc. Hum. Genet., Chapter 2, Unit2.13.
37. Knol,M.J. et al. (2007) Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int. J. Epidemiol., 36, 1111-1118.
38. Wacholder,S. et al. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl Cancer Inst., 96, 434-442.
39. Aqeilan,R.I. et al. (2007) Targeted deletion of Wwox reveals a tumor suppressor function. Proc. Natl Acad. Sci. USA, 104, 3949-3954.
40. Seisenbacher,G. et al. (2011) MK2-dependent p38b signalling protects Drosophila hindgut enterocytes against JNK-induced apoptosis under chronic stress. PLoS Genet., 7, e1002168.
41. Li,Y. et al. (2003) The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3. J. Biol. Chem., 278, 13663-13671.
42. Chakraborty,S. et al. (2008) Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma. BMC Cancer, 8, 163.
43. Lehner,M.D. et al. (2002) Mitogen-activated protein kinase-activated protein kinase 2-deficient mice show increased susceptibility to Listeria monocytogenes infection. J. Immunol., 168, 4667-4673.
44. Zaru,R. et al. (2007) The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nat. Immunol., 8, 1227-1235.
45. Tang,J. et al. (2008) Phosphorylation of Plk1 at Ser326 regulates its functions during mitotic progression. Oncogene, 27, 6635-6645.
46. Stranger,B.E. et al. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science, 315, 848-853.
47. Stankiewicz,P. et al. (2010) Structural variation in the human genome and its role in disease. Annu. Rev. Med., 61, 437-455.
48. Huang,L. et al. (2011) Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk. Carcinogenesis, 33, 94-100.
49. Yang,L. et al. (2013) A functional copy number variation in the WWOX gene is associated with lung cancer risk in Chinese. Hum. Mol. Genet., 22, 1886-1894.